Budget 2015: Generic drug prices expected to fall as Government redirects health spending

Patients are set to benefit from a significant drop in the price of many common drugs as a result of ...

Read more →

PHARMAC decision to award sole supply to Fentanyl Sandoz (fentanyl transdermal patch)

PHARMAC is pleased to announce the award of Sole Subsidised Supply Status in the community, and Hospital Supply Status in ...

Read more →

Pharma and docs up in arms over Cancer Drugs Fund cuts

The list of drugs to be cut from the Cancer Drugs Fund has yet to be confirmed but drugmakers and ...

Read more →

Post-market review of products used for diabetes management

The draft Report from Stage 2 of the Review focussing on Insulin Pumps has now been published and is open for comment. ...

Read more →

Cannabis-based multiple sclerosis drug divides England and Wales

Drug spending authorities in England and Wales have clashed over whether a cannabis-based drug for treating pain in multiple sclerosis ...

Read more →

New therapeutic option now available for select treatment resistant lung cancer patients

Novartis Pharmaceuticals Canada Inc. is pleased to announce that Health Canada has issued a marketing authorization with conditions for Zykadia (ceritinib), a ...

Read more →

CDEC recommends Adempas (riociguat) for certain patients with chronic thromboembolic pulmonary hypertension

The CDEC has recommended that riociguat be listed for the management of inoperable chronic thromboembolic pulmonary hypertension (CTEPH, World Health Organization [WHO] ...

Read more →

Industry calls for reform at cancer medicines Inquiry

Medicines Australia and medicines industry representatives have appeared before the Senate Inquiry into the availability of new, innovative and specialist ...

Read more →

What we already know about the budget

What we know so far about Tuesday's budget ...

Read more →

Government agrees breakthrough drug pricing deal with pharmaceutical firms

[:content [\T \h \e \space \U \K \  \G \o \v \e \r \n \m \e \n \t \space \a \n \d \space \p \h \a \r \m \a \c \e \u \t \i \c \a \l \space \c \o \m \p \a \n \i \e \s \space \h \a \v \e \space \a \g \r \e \e \d \space \a \space \n \e \w \space \f \i \v \e \- \y \e \a \r \, \space \m \u \l \t \i \- \b \i \l \l \i \o \n \space \p \r \i \c \i \n \g \space \d \e \a \l \space \t \h \a \t \space \w \i \l \l \space \i \n \t \r \o \d \u \c \e \space \a \space \f \i \x \e \d \space \l \i \m \i \t \space \o \n " ..."]]
Read more →

NICE calls for a new approach to managing the entry of drugs into the NHS

In its response to comments on proposals for changes to its current methodology for evaluating new drugs, the National Institute ...

Read more →

Drugs for chronic hepatitis C

A document outlining the proposed project scope for CADTH’s project on drugs for chronic hepatitis C is now available for feedback from ...

Read more →

Decisions to list and amend restrictions on various pharmaceuticals

PHARMAC is pleased to announce decisions to list, delist and amend the restrictions for various pharmaceuticals in Section B or ...

Read more →

Slashed drug prices could mean hundreds more for families every year even beyond the PBS

Families will save hundreds of dollars a year for everyday medicines for cholesterol, depression and osteoporosis under changes to pass the ...

Read more →

ThromboGenics’ Jetrea (ocriplasmin) receives positive Common Drug Review in Canada

[:content [\2 \7 \space \D \e \c \e \m \b \e \r \, \space \2 \0 \1 \3 \  \- \space \T \h \r \o \m \b \o \G \e \n \i \c \s \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \o \d \a \y \space \t \h \a \t \space \J \e \t \r \e \a \space \( \o \c \r \i \p \l \a \s \m \i \n \) \  \h \a \s \space \r \e \c \e \i \v \e \d \space \a \space \p \o \s \i \t \i \v \e \space \C \o \m \m \o \n \space \D \r \u \g \space \R \e \v \i \e \w \space \i \n \space \C \a \n \a \d \a \. \space \T \h \r \o \m \b \o \G \e \n \i \c \s \space \s \i \g \n \e \d " ..."]]
Read more →